Related Experiment Video
Updated: Jan 15, 2026

06:51
Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry
Published on: November 14, 2025
287
DualMarker: A Multi-Source Fusion Identification Method for Prognostic Biomarkers of Breast Cancer Based on
IEEE Transactions on Computational Biology and Bioinformatics
|October 13, 2025
Summary
Identifying prognostic biomarkers for breast cancer is crucial for patient outcomes. A new method, DualMarker, uses multi-source biological networks with denoising to improve accuracy in predicting breast cancer prognosis.
Area of Science:
- Bioinformatics
- Computational Biology
- Genomics
Background:
- Breast cancer prognosis prediction is challenging due to complex contributing factors.
- Network-based approaches are used to identify prognostic biomarkers, but single-source networks yield poor accuracy.
- Existing multi-source network integration methods often neglect network denoising, limiting performance.
Purpose of the Study:
- To develop an accurate method for identifying prognostic biomarkers in breast cancer.
- To address the limitations of single-source networks and improve multi-source network integration.
Main Methods:
- Proposed DualMarker, a multi-source fusion method for prognostic biomarker identification.
- Constructed a dual-layer heterogeneous network integrating multiple biological data sources.
- Applied network denoising to mitigate effects of incomplete biological network interactions.
- Utilized network propagation and an initial scoring strategy for feature ranking.
Main Results:
- DualMarker demonstrated superior performance across six breast cancer datasets compared to six other network-based methods.
- Identified biomarkers showed biological interpretability.
- The identified biomarkers were closely associated with breast cancer patient prognosis.
Conclusions:
- DualMarker offers an effective approach for identifying reliable prognostic biomarkers for breast cancer.
- The method's integration of multi-source networks and denoising significantly improves prediction accuracy.
- The identified biomarkers hold potential for clinical application in breast cancer outcome prediction.

